Photo: Oleg Karsaev / “Kommersant”
The drug “Replevin” (Russian brand “of Favipiravir”) for the treatment of coronavirus has shown good results during trials on 30 patients in Smolensk. About it RIA Novosti said the head of infectious Department of clinical hospital №1, Smolensk Elena Simakina on.
Testing began on 8 June. Now patients have passed the stage of treatment came under observation. According to the results, rapidly improve laboratory parameters, out of breath, dry cough, weakness and malaise. There are virtually no side effects. Maybe “Replevin” will also help to significantly reduce the frequency of complications of pneumonia. “In our view, the outcome is beautiful,” said Simakina on.
According to her, the doctors hope this drug, especially if the fall will begin the growth of influenza and coronavirus infection. Simakina on noted that in this case, the drug would be “just a bomb”, because it can be effective against two viruses. “We hope so. It will just be a breakthrough,” she added.
Previously, “Replevin” has been approved by the Ministry of health. Its use is only allowed in the hospital. Previously, the drug used in the treatment of Ebola.
Video, photo All from Russia.